PGEN | PrecigenNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$5.25
+$0.11 (+2.14%)

Precigen (PGEN) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.

The 50 SMA has sat above the 200 on the daily since May 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is above both.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $5.25 vs 50 $7.14 / 200 $5.28
Projection
No cross projected
Test
No active test
Last cross
Golden cross 18 May 2026 ยท projected 11 bars out ยท tested 1 bar

Weekly as of 30 Oct 16:00 ET

Price
above both $6.94 vs 50 $5.08 / 200 $2.45
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 15 Sep 2025 ยท projected 21 bars out

4-hour as of 3 Nov 16:00 ET

Price
below both $5.25 vs 50 $7.00 / 200 $6.48
Projection
Death cross projected in 10 bars
Test
No active test
Last cross
Golden cross 15 May 2026 bar 1 ยท projected 7 bars out ยท tested 3 bars

Cross history

24
crosses on record since 2021
13 golden11 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
18 May 2026Golden moderatedaily11 bars out1 bar cross test
15 May 2026Golden4-hour7 bars out3 bar cross test
7 May 2026Death moderatedaily19 bars outNot tested
11 Mar 2026Death4-hour24 bars outNot tested
week of 15 Sep 2025Golden moderateweekly21 bars outNot tested

About PGEN

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$32.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.